DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for GlycoMimetics, Inc. (GLYC)
« Back to company indexGLYC Chatter Timeline
Stock Ticker for GLYC
Most Active Tweeters for GLYC
| User | Tweets |
|---|---|
| @gcassidy718 | 3 |
| @BlueBioNow | 3 |
| @Estimize | 3 |
| @StockNewsNow | 2 |
| @newsfilterio | 2 |
Recent Tweets for GLYC
 |
@StockNewsNow $GLYC GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019 https://t.co/OtonfxwUI3 February 28th 2020, 12:02pm |
 |
@newsfilterio GlycoMimetics EPS beats by $0.01 $GLYC https://t.co/jk57HTFXAH February 28th 2020, 11:02am |
 |
@AlertTrade UP WITH EARNINGS TODAY ALERT: $GLYC GlycoMimetics, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room February 28th 2020, 10:02am |
 |
@Stock_News_Now $GLYC: New SEC Filing for GLYC: Form 10-K (No. 0001558370-20-001723): https://t.co/fuANdVDoIF February 28th 2020, 8:02am |
 |
@Estimize Well done Roth_30 beating 8 other analysts to take the win for $GLYC - https://t.co/cqdqNmhxOf February 28th 2020, 8:02am |
|
@Estimize $GLYC beats the Estimize EPS Consensus by 1c and misses the Estimize Revenue Consensus by $0.01M. Reports FQ4 earni… https://t.co/YOzgQ1MkL1 February 28th 2020, 8:02am |
|
@Estimize $GLYC reports FQ4 earnings of -34c EPS and $0M Revs - https://t.co/qGyjtpWOUG February 28th 2020, 8:02am |
 |
@MarketCurrents $GLYC - GlycoMimetics EPS beats by $0.01 https://t.co/PJbBGFVRsq February 28th 2020, 8:02am |
 |
@otcdynamics $GLYC GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019 https://t.co/1Ac7SM06F9 February 28th 2020, 8:02am |
|
@newsfilterio GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019 $GLYC https://t.co/VImyXSTGf3 February 28th 2020, 8:02am |
 |
@BlueBioNow $GLYC considerable price movement -3.14 % change recently https://t.co/XgwQoI5WeD February 27th 2020, 10:02pm |
 |
@1stOncology #GlycoMimetics to Present at the Cowen and Company 40th Annual #HealthCareConference 2020 $GLYC https://t.co/aP9fqJ9vYV February 26th 2020, 5:02am |
 |
@gcassidy718 $GLYC Hurting with one -3.02 % change recently https://t.co/OpTFVD2XBu February 25th 2020, 5:02pm |
|
@StockNewsNow $GLYC GlycoMimetics to Present at the Cowen and Company 40th Annual Health Care Conference 2020 https://t.co/y1prsUPAUT February 25th 2020, 5:02pm |
|
@gcassidy718 $GLYC Valuation is starting to make more sense now $3.59. https://t.co/OpTFVD2XBu February 24th 2020, 2:02pm |
|
@BlueBioNow $GLYC I'd like to make an exit, just not now -2.61 % change recently https://t.co/XgwQoI5WeD February 23rd 2020, 6:02pm |
 |
@dispatchtribune GlycoMimetics Inc $GLYC Receives $9.25 Average PT from Analysts https://t.co/n84cvLcgki February 23rd 2020, 12:02pm |
 |
@dakotafinancial GlycoMimetics Inc $GLYC Receives $9.25 Average PT from Analysts https://t.co/p936L5ouRP February 23rd 2020, 12:02pm |
|
@BlueBioNow $GLYC waiting for the turn around . . . -2.61 % change recently https://t.co/XgwQoI5WeD February 22nd 2020, 6:02pm |
 |
@WeekHerald Analysts Set GlycoMimetics Inc $GLYC Target Price at $9.25 https://t.co/ph1g04AjBA February 21st 2020, 10:02am |
 |
@OlympiaReport GlycoMimetics Inc $GLYC Given Average Rating of “Buy” by Brokerages https://t.co/7JIsyzKdnw February 21st 2020, 10:02am |
|
@gcassidy718 $GLYC was oversold imo -2.08 % https://t.co/OpTFVD2XBu February 19th 2020, 11:02am |
 |
@IBD_AGatlin @icer_review $GLYC and $OVID are also developing orphan drugs, though they haven't gained those approvals yet. February 19th 2020, 10:02am |
 |
@TheMarketsDaily GlycoMimetics Inc $GLYC Receives $9.25 Consensus Price Target from Brokerages https://t.co/YxgOn7jby4 February 19th 2020, 6:02am |
 |
@bbnsnews GlycoMimetics Inc $GLYC Receives $9.25 Average PT from Brokerages https://t.co/0aGG3eYtby February 19th 2020, 6:02am |
 |
@sxhalt sold 500 shares $GLYC 4.28. (that 4.50 tp was not meant for today and I'll look to rebuy tomorrow if it pulls back at the open) February 18th 2020, 3:02pm |
|
@sxhalt bougt 700 shares $GLYC @ 4.06. clear support at 4, looking for reversal in 90 day downtrend. tp 4.50 February 18th 2020, 11:02am |
 |
@ThisLincolnian -$0.35 EPS Expected for GlycoMimetics Inc $GLYC This Quarter https://t.co/aAQ4YKgpVQ February 17th 2020, 1:02pm |
 |
@AmericanBanking GlycoMimetics Inc $GLYC Receives Average Recommendation of “Buy” from Brokerages https://t.co/XdMyUqxusw #stocks February 16th 2020, 5:02pm |
 |
@dailypoliticaln GlycoMimetics Inc $GLYC Receives Average Rating of “Buy” from Analysts https://t.co/Dv1OTNnYZV February 16th 2020, 5:02pm |
 |
@TranscriptDaily Zacks: Analysts Expect GlycoMimetics Inc $GLYC Will Announce Earnings of -$0.35 Per Share https://t.co/SMZcV39cc6 February 15th 2020, 9:02am |
|
@Stock_News_Now $GLYC: New SEC Filing for GLYC: Form SC 13G/A (No. 0000921895-20-000539): https://t.co/nXSNWLRz7g February 14th 2020, 3:02pm |
 |
@HealthcareBeat Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $GLYC https://t.co/1PQobHANah February 14th 2020, 3:02pm |
|
@gcassidy718 $GLYC significant stock price movement -2.40 % change recently https://t.co/OpTFVD2XBu February 13th 2020, 12:02pm |
|
@WeekHerald Zacks: Brokerages Expect GlycoMimetics Inc $GLYC to Announce -$0.35 EPS https://t.co/O4ICmXYBFn February 12th 2020, 3:02pm |
|
@AmericanBanking -$0.35 EPS Expected for GlycoMimetics Inc $GLYC This Quarter https://t.co/8PGFn8CJxW #stocks February 12th 2020, 3:02pm |
|
@OlympiaReport -$0.35 EPS Expected for GlycoMimetics Inc $GLYC This Quarter https://t.co/j2JuElvPcr February 12th 2020, 3:02pm |
 |
@endpts Pfizer uncouples from GlycoMimetics and its failed sickle cell disease drug https://t.co/CDRQDG3ueb $PFE $GLYC February 11th 2020, 11:02pm |
 |
@pjl001 Pfizer axes license agreement with GlycoMimetics https://t.co/HjSK7F5Eh0 $PFE, $GLYC Great Dividend Stock BUY PFE! February 11th 2020, 4:02pm |
 |
@felipepotes83 Pfizer $PFE axes license agreement with GlycoMimetics $GLYC https://t.co/i9cvSF6eBx February 11th 2020, 2:02pm |
 |
@StckPro $PFE $GLYC NEW ARTICLE : Pfizer axes license agreement with GlycoMimetics https://t.co/fdcHghFyPY Get all the lates… https://t.co/wxhda6fhV0 February 11th 2020, 1:02pm |
|
@MarketCurrents $PFE $GLYC - Pfizer axes license agreement with GlycoMimetics https://t.co/OupcLFeYgL February 11th 2020, 1:02pm |
 |
@christymaginn RT @jeff_cranmer: $PFE terminates rivipansel deal with $GLYC three months after failed pan-selectin antagonist failed in sickle cell https:… February 10th 2020, 4:02pm |
 |
@jeff_cranmer $PFE terminates rivipansel deal with $GLYC three months after failed pan-selectin antagonist failed in sickle cell… https://t.co/pQQcH9wta7 February 10th 2020, 4:02pm |
|
@Stock_News_Now $GLYC: New SEC Filing for GLYC: Form 8-K (No. 0001558370-20-000636): https://t.co/Y71PVJ9jjr February 10th 2020, 4:02pm |
 |
@Gambiste1 RT @HealthcareBeat: Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $GLYC https://t.co/F… February 9th 2020, 7:02am |
|
@HealthcareBeat Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $GLYC https://t.co/FZeUTfvvsq February 9th 2020, 6:02am |
 |
@WatchlistN GlycoMimetics $GLYC Shares Cross Below 50-Day Moving Average of $4.98 https://t.co/dU8EC1zjJX February 8th 2020, 10:02am |
 |
@ConsumerFeed GlycoMimetics $GLYC Shares Pass Below Fifty Day Moving Average of $4.98 https://t.co/avB2qJMbbB February 8th 2020, 10:02am |
|
@newsfilterio Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $GLYC https://t.co/bBY3zaGQEq February 8th 2020, 5:02am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.